Cartesian Therapeutics, Inc.

NASDAQ:RNAC

Biotechnology

Healthcare
$6.12 -4.15%

-$0.41 today

Market cap
$186.68M
Beta
0.78
P/E (TTM)
-1.7
EPS (TTM)
-$5.65
52W Low $5.60High $15.57

Volume 0.23M

Average 0.26M

Price history

Cartesian Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-19.69%

Period high

$10.59

Period low

$5.84

Latest

$6.12

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 6, 2026Nov 6, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
8-KSep 29, 2026Sep 29, 2026
SC 13GAug 13, 2026Aug 13, 2026
10-QAug 6, 2026Aug 6, 2026
8-KAug 6, 2026Aug 6, 2026
SC 13G/AJul 22, 2026Jul 22, 2026
8-KJun 17, 2026Jun 17, 2026
8-KJun 9, 2026Jun 9, 2026
8-KMay 26, 2026May 26, 2026
SC 13G/AMay 6, 2026May 6, 2026
S-8Apr 30, 2026Apr 30, 2026
10-QApr 30, 2026Apr 30, 2026
8-KApr 30, 2026Apr 30, 2026

Competitors

Who does Cartesian Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about RNAC's filings, answered from its disclosures.

What is the latest RNAC filing?

The latest filing shown is SC 13G/A dated Nov 6, 2026.

How many recent filings does RNAC have?

Intrinsic Alpha currently shows 20 recent filings for RNAC.